SE446265B - 2-metyl-1,4-dihydropyridinforeningar - Google Patents
2-metyl-1,4-dihydropyridinforeningarInfo
- Publication number
- SE446265B SE446265B SE7908367A SE7908367A SE446265B SE 446265 B SE446265 B SE 446265B SE 7908367 A SE7908367 A SE 7908367A SE 7908367 A SE7908367 A SE 7908367A SE 446265 B SE446265 B SE 446265B
- Authority
- SE
- Sweden
- Prior art keywords
- methyl
- dihydropyridine
- carboxylic acid
- compound
- ester
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/56—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB7839978 | 1978-10-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
SE7908367L SE7908367L (sv) | 1980-04-11 |
SE446265B true SE446265B (sv) | 1986-08-25 |
Family
ID=10500226
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7908367A SE446265B (sv) | 1978-10-10 | 1979-10-09 | 2-metyl-1,4-dihydropyridinforeningar |
SE8400689A SE446096B (sv) | 1978-10-10 | 1984-02-09 | Mellanprodukter till anvendning for framstellning av farmakologiskt aktiva 2-metyl-1,4-dihydropyridinforeningar |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8400689A SE446096B (sv) | 1978-10-10 | 1984-02-09 | Mellanprodukter till anvendning for framstellning av farmakologiskt aktiva 2-metyl-1,4-dihydropyridinforeningar |
Country Status (10)
Country | Link |
---|---|
JP (2) | JPS5562065A (ko) |
BE (1) | BE879263A (ko) |
CA (1) | CA1117117A (ko) |
CH (1) | CH642353A5 (ko) |
DE (1) | DE2940833A1 (ko) |
FR (1) | FR2438654A1 (ko) |
GB (1) | GB2036722B (ko) |
IT (1) | IT1125469B (ko) |
NL (1) | NL7907482A (ko) |
SE (2) | SE446265B (ko) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE7910521L (sv) * | 1979-12-20 | 1981-06-21 | Haessle Ab | Nya 2-metyl-6-substituerade-4-(2,3-disubstituerad fenyl)-1,4-dihydropyridin-3,5-diestrar med hypotesiva egenskaper, samt forfarande for deras framstellning, och farmaceutiska beredningar innehallande desamma |
JPS57175164A (en) * | 1981-04-18 | 1982-10-28 | Banyu Pharmaceut Co Ltd | 1,4-dihydropyridine derivative and its preparation |
DE3269219D1 (en) * | 1981-11-17 | 1986-03-27 | Fisons Plc | Dihydropyridines, methods for their production and their formulation and use as pharmaceuticals |
ZA83959B (en) * | 1982-03-10 | 1984-09-26 | Sandoz Ltd | 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them |
CH655110A5 (de) * | 1982-09-03 | 1986-03-27 | Otsuka Pharma Co Ltd | Carbostyrilderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten. |
DE3312216A1 (de) * | 1983-04-05 | 1984-10-11 | Bayer Ag, 5090 Leverkusen | Verfahren zur herstellung von symmetrischen 1,4-dihydropyridincarbonsaeureestern |
JPS6038322A (ja) * | 1983-08-11 | 1985-02-27 | Fujisawa Pharmaceut Co Ltd | ジヒドロピリジンa物質含有易溶性固形製剤 |
GB8412208D0 (en) * | 1984-05-12 | 1984-06-20 | Pfizer Ltd | Quinolone inotropic agents |
GB8431119D0 (en) * | 1984-12-10 | 1985-01-16 | Fujisawa Pharmaceutical Co | Anti-arteriosclerotic composition |
GB8602518D0 (en) * | 1986-02-01 | 1986-03-05 | Wyeth John & Brother Ltd | 1 4-dihydropyridines |
JPS63115890A (ja) * | 1986-10-31 | 1988-05-20 | Nippon Shinyaku Co Ltd | 2位置換1,4−ジヒドロピリジン誘導体 |
US5114946A (en) * | 1987-06-12 | 1992-05-19 | American Cyanamid Company | Transdermal delivery of pharmaceuticals |
ES2043719T3 (es) * | 1987-06-12 | 1994-01-01 | American Cyanamid Co | Administracion de farmacos por via percutanea. |
US5045553A (en) * | 1987-06-24 | 1991-09-03 | Fujisawa Pharmaceutical Company, Ltd. | Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter |
DE3889532T2 (de) * | 1987-12-29 | 1994-08-25 | Fujisawa Pharmaceutical Co | Dihydropyridin-Verbindung zur Verbesserung der Adernausdehnung und Hemmung der Herzhypertrophie. |
DE3888144T2 (de) * | 1987-12-29 | 1994-06-23 | Fujisawa Pharmaceutical Co | Gehirn-Neuron schützendes Mittel, enthaltend eine Dihydropyridin-Verbindung. |
JP2007230869A (ja) * | 2004-04-05 | 2007-09-13 | Takeda Chem Ind Ltd | アルドステロン受容体拮抗剤 |
CN103951608B (zh) * | 2009-08-04 | 2016-04-27 | 喜德生(苏州)医药科技有限公司 | 尼伐地平晶型及其制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1552911A (en) * | 1975-07-02 | 1979-09-19 | Fujisawa Pharmaceutical Co | 1,4 dihydropyridine derivatives and the preparation thereof |
GB1591089A (en) * | 1976-12-17 | 1981-06-10 | Fujisawa Pharmaceutical Co | 1,4-dihydropyridine derivatives and process for preparation thereof |
DE2658183A1 (de) * | 1976-12-22 | 1978-07-06 | Bayer Ag | In 2-position substituierte 1,4- dihydropyridin-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
-
1979
- 1979-09-21 CA CA000336130A patent/CA1117117A/en not_active Expired
- 1979-10-08 BE BE0/197526A patent/BE879263A/fr not_active IP Right Cessation
- 1979-10-08 FR FR7925007A patent/FR2438654A1/fr active Granted
- 1979-10-09 SE SE7908367A patent/SE446265B/sv not_active IP Right Cessation
- 1979-10-09 NL NL7907482A patent/NL7907482A/nl active Search and Examination
- 1979-10-09 JP JP13053079A patent/JPS5562065A/ja active Granted
- 1979-10-09 IT IT26362/79A patent/IT1125469B/it active Protection Beyond IP Right Term
- 1979-10-09 GB GB7935022A patent/GB2036722B/en not_active Expired
- 1979-10-09 DE DE19792940833 patent/DE2940833A1/de active Granted
- 1979-10-10 CH CH912879A patent/CH642353A5/de not_active IP Right Cessation
-
1984
- 1984-02-09 SE SE8400689A patent/SE446096B/sv not_active IP Right Cessation
-
1985
- 1985-09-26 JP JP60214152A patent/JPS61118366A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
CA1117117A (en) | 1982-01-26 |
IT7926362A0 (it) | 1979-10-09 |
IT1125469B (it) | 1986-05-14 |
JPS5562065A (en) | 1980-05-10 |
JPS61118366A (ja) | 1986-06-05 |
FR2438654B1 (ko) | 1983-01-14 |
NL7907482A (nl) | 1980-04-14 |
JPS6125711B2 (ko) | 1986-06-17 |
JPS6143343B2 (ko) | 1986-09-26 |
SE446096B (sv) | 1986-08-11 |
BE879263A (fr) | 1980-04-08 |
FR2438654A1 (fr) | 1980-05-09 |
SE7908367L (sv) | 1980-04-11 |
GB2036722A (en) | 1980-07-02 |
CH642353A5 (de) | 1984-04-13 |
DE2940833C2 (ko) | 1989-01-26 |
SE8400689D0 (sv) | 1984-02-09 |
GB2036722B (en) | 1982-12-01 |
DE2940833A1 (de) | 1980-04-30 |
SE8400689L (sv) | 1984-02-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE446265B (sv) | 2-metyl-1,4-dihydropyridinforeningar | |
US5654309A (en) | Pyridopyrimidine derivatives, their production and use | |
US5411970A (en) | Method of inhibiting lentivirus | |
HU207314B (en) | Process for producing 6-benzoxazinyl- and 6-benzthiazinyl-2,3,4,5-tetrahydropyridazin-3-ones and pharmaceutical compositions containing them | |
US4996204A (en) | Pyrido[2,3-d]pyridazinones as aldose reductase inhibitors | |
JPS635035B2 (ko) | ||
El-Hamouly et al. | Synthesis of new 4-aryl-isoxazolo [5, 4-d] pyrimidin-6-one (thione) and 4-aryl-pyrazolo [3, 4-d]-pyrimidin-6-one derivatives of potential antihypertensive activity | |
JPH04334368A (ja) | 新規抗ビールス化合物 | |
OGAWA et al. | Synthesis and antihypertensive activities of new 1, 4-dihydropyridine derivatives containing a nitrooxy moiety at the 3-ester position | |
KR960009427B1 (ko) | 1,4-디히드로피리딘 유도체, 그의 약학적 조성물 및 그 제조방법 | |
US4021434A (en) | Sodium β-[2,6-dimethyl-3,5-bis(ethoxycarbonyl)-4-(3-nitrophenyl)-1,4-dihydropyridine-1-yl]ethyl sulfate | |
AU656261B2 (en) | New 3-aminochroman spiro compounds, processes for their preparation and pharmaceutical compositions containing them | |
US4782069A (en) | 1,4-Dihydropiridines and their use as antithrombotic drugs | |
US4940708A (en) | 4-arylsulfonyl-3,4-dihydro-2(1H)-quinoxalinone-1-alkanoic acids, esters, and salts | |
US4556739A (en) | 3,4-Dialkoxy-2-alkylcarbonyl analino compounds | |
US4705786A (en) | Novel oxadiazolyl-1,4-dihydropyridines useful as antihypertensive agents | |
EP0207674B1 (en) | 1,4-dihydropyridine derivatives, their preparation and their pharmaceutical use | |
EP0063359B1 (en) | 1,4-dihydropyridine derivatives and processes for preparing the same | |
US4579859A (en) | Vasodilating trinitratoalkyl esters of 2-cyano-1,4-dihydropyridines | |
EP0093945A2 (en) | 1,4-Dihydropyridine derivatives | |
US5364860A (en) | Naphthyridine compounds which inhibit tyrosine kinase and their pharmaceutical compositions | |
US4963554A (en) | 6,7-dimethoxy-1,2-dihydro-2-arylquinazoline-3-oxides | |
US4562256A (en) | 1,6-Dialkyl-3-substituted-4-nitrophenyl-4,7-dihydropyrazolo[3,4-b]pyridine-5-carboxylic acid esters | |
NL8004002A (nl) | Chinolinederivaten en farmaceutische preparaten die een dergelijke verbinding bevatten, alsmede werkwijze voor het bereiden van deze verbindingen. | |
EP0285267A3 (en) | Pyridine derivatives for treatment and prevention of liver damage, and their preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAL | Patent in force |
Ref document number: 7908367-1 Format of ref document f/p: F |
|
NUG | Patent has lapsed |
Ref document number: 7908367-1 Format of ref document f/p: F |